<em>Helicobacter pylori </em> Infection and Related Diseases: Clinical Updates and Perspectives
Helicobacter pylori is one of the most common infections in the world, affecting roughly half of all humans. Although it is not an infection that causes death immediately after infection, it is one of the largest emerging infectious diseases in the history of humankind, causing a wide variety of dis...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_132373 | ||
005 | 20240108 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20240108s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-9555-9 | ||
020 | |a 9783036595542 | ||
020 | |a 9783036595559 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-9555-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Ikuse, Tamaki |4 edt | |
700 | 1 | |a Hojo, Mariko |4 edt | |
700 | 1 | |a Ikuse, Tamaki |4 oth | |
700 | 1 | |a Hojo, Mariko |4 oth | |
245 | 1 | 0 | |a <em>Helicobacter pylori </em> Infection and Related Diseases: Clinical Updates and Perspectives |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (138 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Helicobacter pylori is one of the most common infections in the world, affecting roughly half of all humans. Although it is not an infection that causes death immediately after infection, it is one of the largest emerging infectious diseases in the history of humankind, causing a wide variety of diseases and, in the long term, serious complications such as stomach cancer. This Reprint contains empirical studies and reviews regarding the diagnosis, treatment, complications, and management of H. pylori infection, including new diagnostic methods, effective eradication regimens, the management of gastric cancer, and other topics. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a gastric cancer | ||
653 | |a biliopancreatic reflux | ||
653 | |a gastritis | ||
653 | |a carcinoma | ||
653 | |a endoscopic surveillance | ||
653 | |a Helicobacter pylori infection | ||
653 | |a gastric stump cancer | ||
653 | |a Helicobacter pylori | ||
653 | |a H. pylori | ||
653 | |a rifabutin | ||
653 | |a treatment | ||
653 | |a eradication failure | ||
653 | |a culture | ||
653 | |a bismuth | ||
653 | |a rescue | ||
653 | |a Hp-EuReg | ||
653 | |a third-generation ultrathin endoscope | ||
653 | |a transnasal endoscopy | ||
653 | |a narrow-band imaging | ||
653 | |a Kyoto classification of gastritis | ||
653 | |a gastric atrophy and intestinal metaplasia | ||
653 | |a diagnosis | ||
653 | |a stool antigen test | ||
653 | |a urea breath test | ||
653 | |a peptic ulcer disease | ||
653 | |a triple therapy | ||
653 | |a vonoprazan | ||
653 | |a dyspepsia | ||
653 | |a Kyoto Classification of Gastritis | ||
653 | |a cagA | ||
653 | |a Okinawa | ||
653 | |a endoscopic findings | ||
653 | |a Helicobacter infection | ||
653 | |a tetracycline | ||
653 | |a eradication | ||
653 | |a penicillin allergy | ||
653 | |a furazolidone | ||
653 | |a metronidazole | ||
653 | |a amoxicillin | ||
653 | |a child | ||
653 | |a host genetic factor | ||
653 | |a iron deficiency anemia | ||
653 | |a iron demand | ||
653 | |a iron uptake | ||
653 | |a sports activity | ||
653 | |a virulence factor | ||
653 | |a gastric lymphoma | ||
653 | |a MALT lymphoma | ||
653 | |a radiotherapy | ||
653 | |a chemotherapy | ||
653 | |a rituximab | ||
653 | |a dual therapy | ||
653 | |a vonoprazan (VPZ) | ||
653 | |a amoxicillin (AMOX) | ||
653 | |a clarithromycin (CAM) | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8383 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/132373 |7 0 |z DOAB: description of the publication |